Skip to content

Precept Ticarcillin/Clavulanic Acid

by Austin Biological Laboratories

510(k) K864069

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK864069 Date13 Nov 1986ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Precept (Tm) Ticarcillin/Clavulanic Acid
510(k) Number
FDA Product Code
JWY
Device Class
Class II
Regulation
21 CFR Part 866.1640
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Precept Ticarcillin/Clavulanic Acid is a manual antimicrobial susceptibility test system. It is designed to determine the susceptibility of microorganisms to the antibiotic combination of ticarcillin and clavulanic acid.

This device is classified as a Class 2 medical device under regulation number 866.1640. It received FDA 510(k) clearance on November 13, 1986, under the K864069 submission.

Other devices from Austin Biological Laboratories

See all devices from Austin Biological Laboratories →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary function of the Precept Ticarcillin/Clavulanic Acid system?

    This device is a manual antimicrobial susceptibility test system. It is specifically designed to determine the susceptibility of microorganisms when exposed to the antibiotic combination of ticarcillin and clavulanic acid.

  • What is the regulatory classification of this device?

    The Precept Ticarcillin/Clavulanic Acid system is classified as a Class 2 medical device under regulation number 866.1640. It received FDA 510(k) clearance on November 13, 1986, under submission number K864069.

  • Who is the manufacturer of this susceptibility test system?

    The device is manufactured by Austin Biological Laboratories, located in Austin, Texas. The system is categorized under the microbiology medical specialty.